(Fighting New Coronary Pneumonia) The 47th confirmed patient in Macau is currently in stable condition
China News Service, Macau, January 25 (Reporter Long Tuyou) The Macau Novel Coronavirus Infection Response Coordination Center stated on the 25th that after antibody testing, it was found that the 47th confirmed patient with COVID-19 in Macau had igG antibodies. At least 3 weeks.
The results of viral gene sequencing showed that the patient's samples were not mutated viruses from the United Kingdom, South Africa or Brazil.
According to Luo Yilong, the medical director of the Condeals General Hospital of Macau, the patient is currently in stable clinical condition and has no symptoms of pneumonia. He is currently undergoing isolation treatment.
After the nasopharyngeal swab test was still weakly positive, it is believed that the patient is most likely in the middle and late stages of the disease, which is a phenomenon of rejuvenation.
According to the response coordination, the benefits of vaccination include gaining immunity and creating a herd immune barrier. According to the data currently available, increasing the vaccination rate is the only effective way to create a herd immune barrier.
The three vaccines currently supplied to Australia, including inactivated vaccines, mRNA vaccines and adenovirus vector vaccines, have not presented any major safety issues.
As of January 25, Macau has had no local case reports for 302 consecutive days, no new case reports for 3 consecutive days, and a total of 47 confirmed cases and no deaths.
There has been no community transmission of the new crown pneumonia virus so far, and no medical staff has been infected.
(Finish)